首页> 外文期刊>Molecular medicine reports >Pyropia yezoensis glycoprotein regulates antioxidant status and prevents hepatotoxicity in a rat model of D-galactosamine/lipopolysaccharide-induced acute liver failure
【24h】

Pyropia yezoensis glycoprotein regulates antioxidant status and prevents hepatotoxicity in a rat model of D-galactosamine/lipopolysaccharide-induced acute liver failure

机译:吡喃菊酯糖蛋白调节抗氧化状态并预防肝毒性在D-半乳糖胺/脂多糖诱导的急性肝功能衰竭的大鼠模型中

获取原文
获取原文并翻译 | 示例
           

摘要

The present study aimed to investigate the effects of Pyropia yezoensis glycoprotein (PYGP) on hepatic antioxidative enzyme activity and mitogen-activated protein kinase (MAPK) phosphorylation in a rat model of D-galactosamine/lipopolysaccharide (D-GalN/LPS)-induced hepatotoxicity. Glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) were measured to determine the severity of hepatotoxicity. Treatment with D-GalN/LPS significantly increased the GOT, GPT and lipid peroxidation levels, and decreased the antioxidant capacity of the rats. Treatment with PYGP (150 and 300 mg/kg/body weight) decreased the levels of GOT, GPT and lipid peroxidation levels. The activities of antioxidative enzymes, including catalase, glutathione S-transferase and glutathione were upregulated following PYGP treatment. Furthermore, D-GalN/LPS-induced MAPK phosphorylation, and inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein expression were downregulated by PYGP. These results indicated that PYGP may exert hepatoprotective effects via the upregulation of antioxidative enzymes, and the downregulation of the MAPK signaling pathway and iNOS and COX-2 expression.
机译:本研究旨在探讨吡喃菊酯糖蛋白(PyGP)对D-半乳糖胺/脂多糖(D-GALN / LPS)大鼠模型中肝抗氧化酶活性和丝分裂活化蛋白激酶(MAPK)磷酸化的影响 - 培养肝毒性。测量谷氨酸 - 草酸缩氨酸转氨酶(GOT)和谷氨酰胺 - 丙酮转氨酶(GPT)以确定肝毒性的严重程度。用D-GALN / LPS治疗显着增加GOT,GPT和脂质过氧化水平,并降低了大鼠的抗氧化能力。用PyGP(150和300mg / kg /体重)治疗降低了GOT,GPT和脂质过氧化水平的水平。在PyGP处理后,上调抗氧化酶,包括过氧化氢酶,谷胱甘肽S-转移酶和谷胱甘肽的活性。此外,D-GALN / LPS诱导的MAPK磷酸化和可诱导的一氧化氮合酶(INOS)和环氧氧酶-2(COX-2)蛋白表达被PyGP下调。这些结果表明,PyGP可以通过抗氧化酶的上调和MAPK信号通路和INOS和COX-2表达的下调来发挥肝保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号